Potential drug-drug interactions in pediatric outpatient prescriptions for newborns and infants

Min Li Yeh, Ying Jui Chang, Shu Jen Yeh, Li Jung Huang, Yung Tai Yen, Po Yen Wang, Yu Chuan Li, Chien-Yeh Hsu

研究成果: 雜誌貢獻文章

11 引文 (Scopus)

摘要

Objectives: To surveyed the quantities, types, and related information of potential drug-drug interactions (DDIs) and estimate the off-label use percentage of pediatric outpatient prescriptions for newborns and infants from the National Health Insurance Research Database (NHIRD) of Taiwan. Background: Adverse drug reactions (ADR) may cause morbidity and mortality, potential drug-drug interactions (DDI) increase the probability of ADR. Research on ADR and DDI in infants is of particular urgency and importance but the related profiles in these individuals are not well known. Methods: All prescriptions written by physicians in 2000 were analyzed to identify potential DDIs among drugs appearing on the same prescription sheet. Results: Of a total of 150.6 million prescription sheets, with 669.5 million prescriptions registered in the NHIRD of Taiwan, six million (3.99%) prescription sheets were for 2.1 million infants with 19.4 million (2.85%) prescriptions. There were 672,020 potential DDIs in this category, accounting for 3.53% per prescription; an estimated one DDI in every three patients. The interactions between aspirin and aluminum/magnesium hydroxide were most common (4.42%). Of the most significant drug-drug interactions, the interaction of digoxin with furosemide ranked first (20.14%), followed by the interactions of cisapride with furosemide and erythromycin (6.02% and 4.85%, respectively). The interactions of acetaminophen and anti-cholinergic agents comprised most types of drug-drug interactions (6.62%). Conclusion: Although the prevalence rates of DDIs are low, life-threatening interactions may develop. Physicians must be reminded of the potential DDIs when prescribing medications for newborns and infants.

原文英語
頁(從 - 到)15-22
頁數8
期刊Computer Methods and Programs in Biomedicine
113
發行號1
DOIs
出版狀態已發佈 - 一月 2014

指紋

Drug interactions
Pediatrics
Drug Interactions
Prescriptions
Outpatients
Newborn Infant
Pharmaceutical Preparations
Health insurance
Drug-Related Side Effects and Adverse Reactions
Furosemide
National Health Programs
Taiwan
Research
Databases
Cisapride
Off-Label Use
Physicians
Digoxin
Cholinergic Antagonists
Erythromycin

ASJC Scopus subject areas

  • Computer Science Applications
  • Software
  • Health Informatics

引用此文

Potential drug-drug interactions in pediatric outpatient prescriptions for newborns and infants. / Yeh, Min Li; Chang, Ying Jui; Yeh, Shu Jen; Huang, Li Jung; Yen, Yung Tai; Wang, Po Yen; Li, Yu Chuan; Hsu, Chien-Yeh.

於: Computer Methods and Programs in Biomedicine, 卷 113, 編號 1, 01.2014, p. 15-22.

研究成果: 雜誌貢獻文章

Yeh, Min Li ; Chang, Ying Jui ; Yeh, Shu Jen ; Huang, Li Jung ; Yen, Yung Tai ; Wang, Po Yen ; Li, Yu Chuan ; Hsu, Chien-Yeh. / Potential drug-drug interactions in pediatric outpatient prescriptions for newborns and infants. 於: Computer Methods and Programs in Biomedicine. 2014 ; 卷 113, 編號 1. 頁 15-22.
@article{bf6cfbe5348645c392524169615877c1,
title = "Potential drug-drug interactions in pediatric outpatient prescriptions for newborns and infants",
abstract = "Objectives: To surveyed the quantities, types, and related information of potential drug-drug interactions (DDIs) and estimate the off-label use percentage of pediatric outpatient prescriptions for newborns and infants from the National Health Insurance Research Database (NHIRD) of Taiwan. Background: Adverse drug reactions (ADR) may cause morbidity and mortality, potential drug-drug interactions (DDI) increase the probability of ADR. Research on ADR and DDI in infants is of particular urgency and importance but the related profiles in these individuals are not well known. Methods: All prescriptions written by physicians in 2000 were analyzed to identify potential DDIs among drugs appearing on the same prescription sheet. Results: Of a total of 150.6 million prescription sheets, with 669.5 million prescriptions registered in the NHIRD of Taiwan, six million (3.99{\%}) prescription sheets were for 2.1 million infants with 19.4 million (2.85{\%}) prescriptions. There were 672,020 potential DDIs in this category, accounting for 3.53{\%} per prescription; an estimated one DDI in every three patients. The interactions between aspirin and aluminum/magnesium hydroxide were most common (4.42{\%}). Of the most significant drug-drug interactions, the interaction of digoxin with furosemide ranked first (20.14{\%}), followed by the interactions of cisapride with furosemide and erythromycin (6.02{\%} and 4.85{\%}, respectively). The interactions of acetaminophen and anti-cholinergic agents comprised most types of drug-drug interactions (6.62{\%}). Conclusion: Although the prevalence rates of DDIs are low, life-threatening interactions may develop. Physicians must be reminded of the potential DDIs when prescribing medications for newborns and infants.",
keywords = "Adverse drug reactions, Drug-drug interactions, Information technology, National Health Insurance, Patient safety",
author = "Yeh, {Min Li} and Chang, {Ying Jui} and Yeh, {Shu Jen} and Huang, {Li Jung} and Yen, {Yung Tai} and Wang, {Po Yen} and Li, {Yu Chuan} and Chien-Yeh Hsu",
year = "2014",
month = "1",
doi = "10.1016/j.cmpb.2013.07.016",
language = "English",
volume = "113",
pages = "15--22",
journal = "Computer Methods and Programs in Biomedicine",
issn = "0169-2607",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Potential drug-drug interactions in pediatric outpatient prescriptions for newborns and infants

AU - Yeh, Min Li

AU - Chang, Ying Jui

AU - Yeh, Shu Jen

AU - Huang, Li Jung

AU - Yen, Yung Tai

AU - Wang, Po Yen

AU - Li, Yu Chuan

AU - Hsu, Chien-Yeh

PY - 2014/1

Y1 - 2014/1

N2 - Objectives: To surveyed the quantities, types, and related information of potential drug-drug interactions (DDIs) and estimate the off-label use percentage of pediatric outpatient prescriptions for newborns and infants from the National Health Insurance Research Database (NHIRD) of Taiwan. Background: Adverse drug reactions (ADR) may cause morbidity and mortality, potential drug-drug interactions (DDI) increase the probability of ADR. Research on ADR and DDI in infants is of particular urgency and importance but the related profiles in these individuals are not well known. Methods: All prescriptions written by physicians in 2000 were analyzed to identify potential DDIs among drugs appearing on the same prescription sheet. Results: Of a total of 150.6 million prescription sheets, with 669.5 million prescriptions registered in the NHIRD of Taiwan, six million (3.99%) prescription sheets were for 2.1 million infants with 19.4 million (2.85%) prescriptions. There were 672,020 potential DDIs in this category, accounting for 3.53% per prescription; an estimated one DDI in every three patients. The interactions between aspirin and aluminum/magnesium hydroxide were most common (4.42%). Of the most significant drug-drug interactions, the interaction of digoxin with furosemide ranked first (20.14%), followed by the interactions of cisapride with furosemide and erythromycin (6.02% and 4.85%, respectively). The interactions of acetaminophen and anti-cholinergic agents comprised most types of drug-drug interactions (6.62%). Conclusion: Although the prevalence rates of DDIs are low, life-threatening interactions may develop. Physicians must be reminded of the potential DDIs when prescribing medications for newborns and infants.

AB - Objectives: To surveyed the quantities, types, and related information of potential drug-drug interactions (DDIs) and estimate the off-label use percentage of pediatric outpatient prescriptions for newborns and infants from the National Health Insurance Research Database (NHIRD) of Taiwan. Background: Adverse drug reactions (ADR) may cause morbidity and mortality, potential drug-drug interactions (DDI) increase the probability of ADR. Research on ADR and DDI in infants is of particular urgency and importance but the related profiles in these individuals are not well known. Methods: All prescriptions written by physicians in 2000 were analyzed to identify potential DDIs among drugs appearing on the same prescription sheet. Results: Of a total of 150.6 million prescription sheets, with 669.5 million prescriptions registered in the NHIRD of Taiwan, six million (3.99%) prescription sheets were for 2.1 million infants with 19.4 million (2.85%) prescriptions. There were 672,020 potential DDIs in this category, accounting for 3.53% per prescription; an estimated one DDI in every three patients. The interactions between aspirin and aluminum/magnesium hydroxide were most common (4.42%). Of the most significant drug-drug interactions, the interaction of digoxin with furosemide ranked first (20.14%), followed by the interactions of cisapride with furosemide and erythromycin (6.02% and 4.85%, respectively). The interactions of acetaminophen and anti-cholinergic agents comprised most types of drug-drug interactions (6.62%). Conclusion: Although the prevalence rates of DDIs are low, life-threatening interactions may develop. Physicians must be reminded of the potential DDIs when prescribing medications for newborns and infants.

KW - Adverse drug reactions

KW - Drug-drug interactions

KW - Information technology

KW - National Health Insurance

KW - Patient safety

UR - http://www.scopus.com/inward/record.url?scp=84887816302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887816302&partnerID=8YFLogxK

U2 - 10.1016/j.cmpb.2013.07.016

DO - 10.1016/j.cmpb.2013.07.016

M3 - Article

C2 - 24209715

AN - SCOPUS:84887816302

VL - 113

SP - 15

EP - 22

JO - Computer Methods and Programs in Biomedicine

JF - Computer Methods and Programs in Biomedicine

SN - 0169-2607

IS - 1

ER -